NM_022356.4:c.2152C>G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_022356.4(P3H1):​c.2152C>G​(p.Pro718Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000371 in 1,555,520 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P718P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00032 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00038 ( 4 hom. )

Consequence

P3H1
NM_022356.4 missense

Scores

1
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:4

Conservation

PhyloP100: 0.717

Publications

2 publications found
Variant links:
Genes affected
P3H1 (HGNC:19316): (prolyl 3-hydroxylase 1) This gene encodes an enzyme that is a member of the collagen prolyl hydroxylase family. These enzymes are localized to the endoplasmic reticulum and their activity is required for proper collagen synthesis and assembly. Mutations in this gene are associated with osteogenesis imperfecta type VIII. Three alternatively spliced transcript variants encoding different isoforms have been described. Other variants may exist, but their biological validity has not been determined. [provided by RefSeq, Aug 2011]
P3H1 Gene-Disease associations (from GenCC):
  • osteogenesis imperfecta type 8
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0031007528).
BP6
Variant 1-42746756-G-C is Benign according to our data. Variant chr1-42746756-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 194557.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000322 (49/152300) while in subpopulation EAS AF = 0.00889 (46/5176). AF 95% confidence interval is 0.00685. There are 0 homozygotes in GnomAd4. There are 21 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022356.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
P3H1
NM_022356.4
MANE Select
c.2152C>Gp.Pro718Ala
missense
Exon 15 of 15NP_071751.3
P3H1
NM_001243246.2
c.*156C>G
3_prime_UTR
Exon 14 of 14NP_001230175.1
P3H1
NM_001146289.2
c.*77C>G
3_prime_UTR
Exon 15 of 15NP_001139761.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
P3H1
ENST00000296388.10
TSL:1 MANE Select
c.2152C>Gp.Pro718Ala
missense
Exon 15 of 15ENSP00000296388.5
P3H1
ENST00000397054.7
TSL:1
c.*77C>G
3_prime_UTR
Exon 15 of 15ENSP00000380245.3
P3H1
ENST00000460031.5
TSL:5
n.2344C>G
non_coding_transcript_exon
Exon 14 of 14

Frequencies

GnomAD3 genomes
AF:
0.000322
AC:
49
AN:
152182
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00887
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000859
AC:
140
AN:
162942
AF XY:
0.000660
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000399
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0114
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000155
Gnomad OTH exome
AF:
0.000440
GnomAD4 exome
AF:
0.000376
AC:
528
AN:
1403220
Hom.:
4
Cov.:
31
AF XY:
0.000355
AC XY:
246
AN XY:
692516
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31732
American (AMR)
AF:
0.0000278
AC:
1
AN:
35924
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25212
East Asian (EAS)
AF:
0.0134
AC:
481
AN:
35952
South Asian (SAS)
AF:
0.0000627
AC:
5
AN:
79718
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49636
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5700
European-Non Finnish (NFE)
AF:
0.0000185
AC:
20
AN:
1081106
Other (OTH)
AF:
0.000361
AC:
21
AN:
58240
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
39
78
118
157
196
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000322
AC:
49
AN:
152300
Hom.:
0
Cov.:
32
AF XY:
0.000282
AC XY:
21
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41570
American (AMR)
AF:
0.00
AC:
0
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00889
AC:
46
AN:
5176
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68020
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000438
ExAC
AF:
0.000633
AC:
70
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Oct 20, 2014
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 15, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Osteogenesis imperfecta type 8 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Osteogenesis Imperfecta, Recessive Uncertain:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.

P3H1-related disorder Benign:1
Mar 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.051
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
6.3
DANN
Benign
0.70
DEOGEN2
Benign
0.12
T
Eigen
Benign
-0.93
Eigen_PC
Benign
-0.94
FATHMM_MKL
Benign
0.23
N
LIST_S2
Benign
0.49
T
MetaRNN
Benign
0.0031
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
0.72
PROVEAN
Benign
-0.82
N
REVEL
Benign
0.046
Sift
Benign
0.11
T
Sift4G
Benign
0.83
T
Polyphen
0.10
B
Vest4
0.19
MutPred
0.096
Loss of glycosylation at P718 (P = 0.0164)
MVP
0.24
ClinPred
0.018
T
GERP RS
2.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.031
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs533729683; hg19: chr1-43212427; API